Development and validation of HPLC and HPTLC methods for quantification of ebastine in tablets

Indian Drugs

Volumn 41, Issue 3, 2004, Pages 149-152

  Sunitha, P G ^a   Vaidhyalingam, V ^a   Shantha, A ^a   Ezhil Muthu, R P ^b  

^a MADRAS MEDICAL COLLEGE   (India)

^b Erode College of Pharmacy   (India)

Author keywords

Ebastine; HPLC; HPTLC; Tablets; Validation

Indexed keywords

EID: 77954752802     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Current Index of Medical Specialities- 77, Medimedia Health Pvt. Limited , Bangalore, April 2002 (Update 2), pp.19.
2. nd edition, Kathleen Parfitt, The Pharmaceutical Press, London, 1999, pp.410.
3. Matsuda M, Mizuki Y, Terauchi Y, Simultaneous determination of the histamine H1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using highperformance liquid chromatography, J Chromatogr B: Biom Sci Appl 2001, Jun 5;757(1), pp.173-179.
4. Yoshida K, Hatoyama T, Fujii T, Kagemoto A, Miyazaki H, Naruto S, Identification of rat faecal metabolites of ebastine by B/E linked scanning liquid secondary ion mass spectrometry, Biol Mass Spectrom 1994, Jul;23 (7), pp.385-390.
5. Blanco M, Coello J, Gonzalez F, Iturriaga H, Thomas X, Spectrophotometric determination of pharmaceutical dosages by partial least - squares calibration, J. Pharm Biom Anal 1994, (Apr) 12, pp.509-514.